Skip to main content

Closed

OMER: Omeros Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-1063.9%

ROIC-40.6%

Financially safe

Stretched

Debt / equity-4.90×

Interest coverage-7.2×

Current ratio3.03×

Valuation

Unrated

P/E ratio9.1×

Omeros Corporation

OMERNASDAQ Global Market·USD·Closed

Omeros Corporation

OMERNASDAQ·USD·Closed

$11.84

−0.75%

$11.84

−$0.09 (0.75%)

52W Range

59thpctl

Volume

0.69×avg

Mkt Cap

856.92MUSD

P/E

9.1TTM

Div Yield

–ann

52W Range

59thpctl

Volume

0.69×avg

Market Cap

856.92MUSD

P/E Ratio

9.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings